2013
DOI: 10.1016/j.ejmech.2013.07.057
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of quinoidal molecules: Strategies towards bioactive compounds with an emphasis on lapachones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
46
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 102 publications
(47 citation statements)
references
References 119 publications
1
46
0
Order By: Relevance
“…We discovered a series of lapachones with modified C-rings (Scheme 1a) with potent activity against cancer lineages [27]. Lately, interest in preparing quinone-based triazoles has been stimulated by our discovery of bioactive compounds endowed with unique subunits in their chemical structures [28].…”
Section: Introductionmentioning
confidence: 99%
“…We discovered a series of lapachones with modified C-rings (Scheme 1a) with potent activity against cancer lineages [27]. Lately, interest in preparing quinone-based triazoles has been stimulated by our discovery of bioactive compounds endowed with unique subunits in their chemical structures [28].…”
Section: Introductionmentioning
confidence: 99%
“…[12] On the basis of our experience in developing phenazinic derivatives, herein we describe the synthesis of a probe for Cd 2+ , the design of which was based on the phenazine fluorophore and N,Nbis(2-picolyl)amine as a coordination site bound by a 1,2,3-triazolyl unity, as shown in Scheme 1.…”
Section: Introductionmentioning
confidence: 99%
“…The natural compound lapachol is the most plentiful naphthoquinoidal compound isolated from the trees of the family Bignoniaceae and has been extensively studied because of its imperative biological activities, including antitumor effect . β‐Lapachone as the most promising compound of the lapachol group is cytotoxic to a diversity of human cancer cells which are naturally more liable to oxidative damage compared to normal cells . β‐Lapachone has been extensively studied in recent years and is now in phase II clinical trials as a monotherapy or in combination with other antitumor drugs .…”
Section: Introductionmentioning
confidence: 99%